Abstracts (HTML) List of Authors

Galer, Bradley S.

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Gammaitoni, Arnold

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Garbade, Sven

P 781. A Cross-sectional Quantitative Analysis of the Natural History of Farber Disease: An Ultra-Orphan Condition with Rheumatologic and Neurological Cardinal Disease Features

Garbade, Sven F.

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Gärtner, Jutta

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Gattinger, Norbert

FV 588. Probing Homeostatic and Metaplastic Mechanisms of Synaptic Plasticity in Human Primary Motor Cortex Using High-Frequent Quadri-pulse Theta Burst Stimulation

Geiger, Julia

P 295. Everolimus Trial for a Patient with Bannayan–Riley–Ruvalcaba’s Syndrome and Progressive Lipomatosis

Gellrich, Janine

P 379. Objective Assessment of Central Nervous Odor Processing in Infancy

Genrich, Geeske

P 1176. Unfamiliar Interactions of Antiepileptic Drugs

Gerstl, Julia

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

Gerstl, Lucia

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project
FV 510. Influence of Anticonvulsive Treatment on the EEG and the Neuropsychological Features in Children with Rolandic Epilepsy
FV 257. Munich Early Recognition of Childhood Stroke—More than a FAST Screening Tool
FV 396. Childhood Hemorrhagic Stroke—A 7-Year Single-Center Experience
FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community
FV 394. Childhood Arterial Ischaemic Stroke—Results of a German Nationwide Surveillance Study 2015 to 2017

Gill, Esther

P 328. Novel Homozygous Variants Confirm SPTBN4-Related Congenital Myopathy and Expand the Clinical Phenotype

Gil-Nagel, Antonio

IP 112. Cannabidiol Treatment Effect and Adverse Events in Patients with Lennox–Gastaut’s syndrome: Pooled Results from Two Trials

Gissen, Paul

FV 1183. Long-Term Safety and Efficacy of Intraventricular Enzyme Replacement Therapy in CLN2 Disease: 2-Year Results from an Ongoing Multicenter Extension Study

Glaser, Tanja

P 327. Is Video-Assisted Methylphenidate Dose Finding for Children with ADHD a Suitable Procedure for Medical Practitioners?—Results after 4-Year-Follow-up

Gläser, Dieter

P 913. Heterozygous Nonsense Variant in the TCF20 Gene as a Cause of Congenital Myopathy

Gleich, Bernhard

FV 588. Probing Homeostatic and Metaplastic Mechanisms of Synaptic Plasticity in Human Primary Motor Cortex Using High-Frequent Quadri-pulse Theta Burst Stimulation

Gnann, Silja

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

Goelz, Rangmar

FV 930. Reduced Structural Connectivity in Nonmotor Networks in Children Born Preterm

Gonzalez-Fassreiner, Daniela

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

Göpel, Wolfgang

FV 1170. What Influences Motor Function in VLBW Preterm at 5 Years of Age?

Gratzki, Nils

P 1014. Neurodevelopmental Outcome in VLWB Preterm Infants with Neonatal Seizures Born between 2008 and 2011 at the Age of 2 Years

Grehten, Patrice

P 233. Thiamine Pyrophosphokinase Deficiency due to Mutations in the TPK1 Gene: A Rare, Treatable Neurodegenerative Disorder

Grimmel, Mona

FV 943. Facilitating a Molecular Diagnosis as Soon as Possible: Diagnostic Exome in Neurometabolic Disorders

Gröschel, Samuel

FV 930. Reduced Structural Connectivity in Nonmotor Networks in Children Born Preterm
FV 300. Living with Severe Rare Chronic Neurological Disease in Childhood: Family Burden and Quality of Life in Families with MLD and PCH2
FV 188. Morbus Krabbe: One disease—Two Faces
FV 948. Diffusion Tensor Imaging Parameters in Metachromatic Leukodystrophy: Biomarkers for Disease Progress and Therapeutically Therapeutic Evaluation

Gross, Stephanie

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Gruber-Sedlmayr, Ursula

P 788. MOG-Ab Positive Acute Disseminated Encephalomyelitis with Asymmetric Lesions in Basal Ganglia and in Thalami
P 1030. MRI Pattern in Neurodegeneration with Brain Iron Accumulation and Fucosidosis Appear Similar

Grulich-Henn, Jürgen

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

Grünert, Sarah C.

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Guyot, P.

IP 467. Botulinum Toxin Type A in the Management of Spasticity in Children—A Systematic Literature Review and Bayesian Network Meta-analysis